Rapid Sequence Intubation
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Prospective Study of Induction Medications Used in the Trauma RSI
Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements
Rapid Sequence Intubation and Hemodynamic Disorders in the Operating Room: a Prospective Multicenter Observational Study
Rapid Sequence Intubation With Rocuronium in Elderly Patients
Preoperative Presence of Gastric Content in Non-fasting Patients - an Ultrasound Study
Rapid Sequence Intubation With Rocuronium-Sugammadex Compared With Succinylcholine